Skip to main content
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1981 Apr;34(4):400–403. doi: 10.1136/jcp.34.4.400

Prevalence and persistence of C1q binding activity in healthy subjects.

S M Walker, S F Al Khateeb
PMCID: PMC493299  PMID: 7240428

Abstract

Samples of serum from 885 normal healthy blood donors were tested for the presence of soluble immune complex-like material by a solid-phase C1q binding assay. The majority of donors (93%) had low or undetectable levels of C1q binding activity in their sera, but 6% had levels that were clearly outside the normal distribution. When these individuals were retested after several weeks half of them still had elevated levels of C1q binding activity.

Full text

PDF
400

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Eisenberg R. A., Theofilopoulos A. N., Dixon F. J. Use of bovine conglutinin for the assay of immune complexes. J Immunol. 1977 Apr;118(4):1428–1434. [PubMed] [Google Scholar]
  2. Farrell C., Sogaard H., Svehag S. E. Detection of IgG aggregates or immune complexes using solid-phase C1q and protein A-rich Staphylococcus aureus as an indicator system. Scand J Immunol. 1975;4(7):673–680. doi: 10.1111/j.1365-3083.1975.tb02675.x. [DOI] [PubMed] [Google Scholar]
  3. HUNTER W. M., GREENWOOD F. C. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature. 1962 May 5;194:495–496. doi: 10.1038/194495a0. [DOI] [PubMed] [Google Scholar]
  4. Hay F. C., Nineham L. J., Roitt I. M. Routine assay for the detection of immune complexes of known immunoglobulin class using solid phase C1q. Clin Exp Immunol. 1976 Jun;24(3):396–400. [PMC free article] [PubMed] [Google Scholar]
  5. Reed A. H., Henry R. J., Mason W. B. Influence of statistical method used on the resulting estimate of normal range. Clin Chem. 1971 Apr;17(4):275–284. [PubMed] [Google Scholar]
  6. Rossen R. D., Reisberg M. A., Hersh E. M., Gutterman J. U. The C1q binding test for soluble immune complexes: clinical correlations obtained in patients with cancer. J Natl Cancer Inst. 1977 May;58(5):1205–1215. doi: 10.1093/jnci/58.5.1205. [DOI] [PubMed] [Google Scholar]
  7. Svehag S. E. A solid-phase radioimmunoassay for C1q-binding immune complexes. I. Delta IgG as indicator molecule. Scand J Immunol. 1975;4(7):687–697. doi: 10.1111/j.1365-3083.1975.tb02677.x. [DOI] [PubMed] [Google Scholar]
  8. Theofilopoulos A. N., Andrews B. S., Urist M. M., Morton D. L., Dixon F. J. The nature of immune complexes in human cancer sera. J Immunol. 1977 Aug;119(2):657–663. [PubMed] [Google Scholar]
  9. Yonemasu K., Stroud R. M. Clq: rapid purification method for preparation of monospecific antisera and for biochemical studies. J Immunol. 1971 Feb;106(2):304–313. [PubMed] [Google Scholar]
  10. Zubler R. H., Lange G., Lambert P. H., Miescher P. A. Detection of immune complexes in unheated sera by modified 125I-Clq binding test. Effect of heating on the binding of Clq by immune complexes and application of the test to systemic lupus erythematosus. J Immunol. 1976 Jan;116(1):232–235. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES